196 related articles for article (PubMed ID: 9412782)
21. High frequency of W1327X mutation in glycogen storage disease type III patients from central Tunisia.
Cherif W; Ben Rhouma F; Messai H; Mili A; Gribaa M; Kefi R; Ayadi A; Boughamoura L; Chemli J; Saad A; Kaabachi N; Sfar MT; Ben Dridi MF; Tebib N; Abdelhak S
Ann Biol Clin (Paris); 2012; 70(6):648-50. PubMed ID: 23207808
[TBL] [Abstract][Full Text] [Related]
22. Glycogen storage disease type IIIa presenting as non-ketotic hypoglycemia: use of a newly approved commercially available mutation analysis to non-invasively confirm the diagnosis.
Seigel J; Weinstein DA; Hillman R; Colbert B; Matthews B; Bachrach B
J Pediatr Endocrinol Metab; 2008 Jun; 21(6):587-90. PubMed ID: 18717245
[TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype correlation in two frequent mutations and mutation update in type III glycogen storage disease.
Shaiu WL; Kishnani PS; Shen J; Liu HM; Chen YT
Mol Genet Metab; 2000 Jan; 69(1):16-23. PubMed ID: 10655153
[TBL] [Abstract][Full Text] [Related]
24. Molecular characterization of Egyptian patients with glycogen storage disease type IIIa.
Endo Y; Fateen E; Aoyama Y; Horinishi A; Ebara T; Murase T; Shin YS; Okubo M
J Hum Genet; 2005; 50(10):538-542. PubMed ID: 16189622
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].
Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F
Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of glycogen storage disease type III.
Shen JJ; Chen YT
Curr Mol Med; 2002 Mar; 2(2):167-75. PubMed ID: 11949933
[TBL] [Abstract][Full Text] [Related]
27. The adult polyglucosan body disease mutation GBE1 c.1076A>C occurs at high frequency in persons of Ashkenazi Jewish background.
Hussain A; Armistead J; Gushulak L; Kruck C; Pind S; Triggs-Raine B; Natowicz MR
Biochem Biophys Res Commun; 2012 Sep; 426(2):286-8. PubMed ID: 22943850
[TBL] [Abstract][Full Text] [Related]
28. [Molecular genetic analysis of 10 Chinese patients with glycogen storage disease type III].
Wang X; Qiu WJ; Ye J; Han LS; Zhang HW; Jiang LR; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):416-20. PubMed ID: 19951465
[TBL] [Abstract][Full Text] [Related]
29. Dysferlinopathy in the Jews of the Caucasus: a frequent mutation in the dysferlin gene.
Leshinsky-Silver E; Argov Z; Rozenboim L; Cohen S; Tzofi Z; Cohen Y; Wirguin Y; Dabby R; Lev D; Sadeh M
Neuromuscul Disord; 2007 Dec; 17(11-12):950-4. PubMed ID: 17825554
[TBL] [Abstract][Full Text] [Related]
30. Glycogen Storage Disease type II: genetic and biochemical analysis of novel mutations in infantile patients from Turkish ancestry.
Hermans MM; Kroos MA; Smeitink JA; van der Ploeg AT; Kleijer WJ; Reuser AJ
Hum Mutat; 1998; 11(3):209-15. PubMed ID: 9521422
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey.
Endo Y; Horinishi A; Vorgerd M; Aoyama Y; Ebara T; Murase T; Odawara M; Podskarbi T; Shin YS; Okubo M
J Hum Genet; 2006; 51(11):958-963. PubMed ID: 17047887
[TBL] [Abstract][Full Text] [Related]
32. Genetic analysis and clinical assessment of four patients with Glycogen Storage Disease Type IIIa in China.
Zhang Y; Xu M; Chen X; Yan A; Zhang G; Liu Z; Qiu W
BMC Med Genet; 2018 Apr; 19(1):54. PubMed ID: 29614965
[TBL] [Abstract][Full Text] [Related]
33. A founder splice site mutation underlies glycogen storage disease type 3 in consanguineous Saudi families.
Basit S; Malibari O; Al Balwi AM; Abdusamad F; Abu Ismail F
Ann Saudi Med; 2014; 34(5):390-5. PubMed ID: 25827695
[TBL] [Abstract][Full Text] [Related]
34. Prenatal diagnosis of glycogen storage disease type Ia by restriction enzyme digestion.
Trioche P; Francoual J; Audibert F; Chalas J; Lindenbaum A; Odièvre M; Labrune P
Prenat Diagn; 1998 Jun; 18(6):629-31. PubMed ID: 9664612
[TBL] [Abstract][Full Text] [Related]
35. Molecular and clinical delineation of 12 patients with glycogen storage disease type III in Western Turkey.
Okubo M; Ucar SK; Podskarbi T; Murase T; Shin YS; Coker M
Clin Chim Acta; 2015 Jan; 439():162-7. PubMed ID: 25451950
[TBL] [Abstract][Full Text] [Related]
36. Phenylketonuria and glycogen storage disease type III in sibs of one family.
Yilmazer T; van Gennip AH; Abeling NG; Ozalp I; Coşkun T; Bakker HD
Turk J Pediatr; 2002; 44(1):49-53. PubMed ID: 11859869
[TBL] [Abstract][Full Text] [Related]
37. Mouse model of glycogen storage disease type III.
Liu KM; Wu JY; Chen YT
Mol Genet Metab; 2014 Apr; 111(4):467-76. PubMed ID: 24613482
[TBL] [Abstract][Full Text] [Related]
38. Novel AGL mutation in a Turkish patient with glycogen storage disease type IIIa.
Aoyama Y; Endo Y; Ebara T; Murase T; Shin YS; Podskarbi T; Ozer I; Demirkol M; Gökçay G; Okubo M
Pediatr Int; 2010 Feb; 52(1):145-7. PubMed ID: 20158661
[No Abstract] [Full Text] [Related]
39. Egyptian glycogen storage disease type III - identification of six novel AGL mutations, including a large 1.5 kb deletion and a missense mutation p.L620P with subtype IIId.
Endo Y; Fateen E; El Shabrawy M; Aoyama Y; Ebara T; Murase T; Podskarbi T; Shin YS; Okubo M
Clin Chem Lab Med; 2009; 47(10):1233-8. PubMed ID: 19754354
[TBL] [Abstract][Full Text] [Related]
40. Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene.
Lossos A; Meiner Z; Barash V; Soffer D; Schlesinger I; Abramsky O; Argov Z; Shpitzen S; Meiner V
Ann Neurol; 1998 Dec; 44(6):867-72. PubMed ID: 9851430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
